Defining the priority of using 18F-FDG PET for recurrent cervical cancer.
Yen TC, See LC, Chang TC, Huang KG, Ng KK, Tang SG, Chang YC, Hsueh S, Tsai CS, Hong JH, Lin CT, Chao A, Ma SY, Lin WJ, Fu YK, Fan CC, Lai CH.
Yen TC, et al. Among authors: chao a.
J Nucl Med. 2004 Oct;45(10):1632-9.
J Nucl Med. 2004.
PMID: 15471826
Free article.
Clinical Trial.